Premium
Stereoselective accumulation of the β‐receptor blocking drug atenolol by human platelets
Author(s) -
Walle T.,
Webb J. G.,
Walle U. K.,
Bagwell E. E.
Publication year - 1991
Publication title -
chirality
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.43
H-Index - 77
eISSN - 1520-636X
pISSN - 0899-0042
DOI - 10.1002/chir.530030607
Subject(s) - chemistry , atenolol , platelet , antagonist , enantiomer , reserpine , pharmacology , desipramine , stereoselectivity , in vitro , receptor , stereochemistry , biochemistry , medicine , blood pressure , hippocampus , antidepressant , catalysis
We have studied the stereochemistry of accumulation of the hydrophilic β‐adrenoceptor antagonist rac‐atenolol by human platelets in vitro. The accumulation was slow, not reaching equilibrium until 90 min at 37°C. The uptake was temperature dependent with the accumulation at 37°C being 3–4 times greater than at 4°C. The accumulation was also stereoselective at 37°C, favoring the active (−)‐enantiomer over the (+)‐enantiomer by 2.3‐fold. Reserpine, but not desipramine, inhibited the platelet accumulation of rac‐atenolol enantiospecifically. This uptake profile is different from the platelet uptake of lipophilic β‐blockers, which is characterized by nonspecific membrane binding, but similar to the carrier‐mediated accumulation of the neurotransmitter norepinephrine by storage granules within the platelet.